SCHEMBL14617263

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL13556126	0.84	CA1 (0.31)	—
	SCHEMBL13556122	0.84	CES2 (0.31)	—
	SCHEMBL26163181	0.84	POLB (0.30)	POLBNPSR1
	SCHEMBL16543404	0.82	CA1 (0.32)	—
	SCHEMBL15134088	0.82	HTT (0.31)	—
	SCHEMBL15134087	0.82	LMNA (0.31)	—
	SCHEMBL18845047	0.81	POLB (0.31)	POLBNPSR1
	SCHEMBL17548747	0.81	CA1 (0.38)	—
	SCHEMBL25633247	0.81	POLB (0.31)	POLBNPSR1
	SCHEMBL24142373	0.81	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.